Matthew C Schwartz1, Andrew C Glatz2, Kaitlyn Daniels2, David J Goldberg2, Elizabeth Rand3, Monica S Epelman4, Meryl S Cohen2. 1. Division of Cardiology, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania. Electronic address: matthew.schwartz@orlandohealth.com. 2. Division of Cardiology, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania. 3. Division of Gastroenterology, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania. 4. Division of Radiology, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.
Abstract
BACKGROUND: Progressive hepatic fibrosis is common after the Fontan operation, but little is known about its onset. We sought to determine whether hepatic abnormalities before the Fontan operation, and whether further abnormalities can be identified soon afterward. METHODS: Patients undergoing the Fontan operation at our institution were prospectively enrolled and underwent hepatic ultrasound with Doppler and serum testing immediately before and 3 to 6 months after the operation. RESULTS: Thirty patients were enrolled at a median age of 3.1 years (range, 2.2 to 8.1 years). Extracardiac Fontan was performed in 67%. Three patients (10%) had abnormal hepatic echotexture before the operation. At the post-Fontan study, mean liver length increased (9.9 versus 10.9 cm; p < 0.0001), and mean hepatic artery end-diastolic velocity decreased (18.8 versus 14.5 cm/s; p = 0.03). One patient showed new, abnormal hepatic echotexture after surgery. Mean aspartate aminotransferase (56.7 versus 60.7 U/L; p = 0.04), alanine transaminase (18.9 versus 33.9 U/L; p = 0.0002), and γ-glutamyl transferase (18.7 versus 46.1 U/L; p = 0.002) increased at the post-Fontan assessment compared with the preoperative values. By linear regression, hospital length of stay and duration with chest tube after Fontan operation were both significantly associated with an increase in γ-glutamyl transferase (p < 0.001 for both) and alanine transaminase (p = 0.008, p = 0.048). CONCLUSIONS: In this cohort, hepatic abnormalities were observed in some patients before the Fontan operation and new abnormalities developed soon afterward. These findings suggest that liver insult may occur before or soon after the Fontan operation.
BACKGROUND: Progressive hepatic fibrosis is common after the Fontan operation, but little is known about its onset. We sought to determine whether hepatic abnormalities before the Fontan operation, and whether further abnormalities can be identified soon afterward. METHODS:Patients undergoing the Fontan operation at our institution were prospectively enrolled and underwent hepatic ultrasound with Doppler and serum testing immediately before and 3 to 6 months after the operation. RESULTS: Thirty patients were enrolled at a median age of 3.1 years (range, 2.2 to 8.1 years). Extracardiac Fontan was performed in 67%. Three patients (10%) had abnormal hepatic echotexture before the operation. At the post-Fontan study, mean liver length increased (9.9 versus 10.9 cm; p < 0.0001), and mean hepatic artery end-diastolic velocity decreased (18.8 versus 14.5 cm/s; p = 0.03). One patient showed new, abnormal hepatic echotexture after surgery. Mean aspartate aminotransferase (56.7 versus 60.7 U/L; p = 0.04), alanine transaminase (18.9 versus 33.9 U/L; p = 0.0002), and γ-glutamyl transferase (18.7 versus 46.1 U/L; p = 0.002) increased at the post-Fontan assessment compared with the preoperative values. By linear regression, hospital length of stay and duration with chest tube after Fontan operation were both significantly associated with an increase in γ-glutamyl transferase (p < 0.001 for both) and alanine transaminase (p = 0.008, p = 0.048). CONCLUSIONS: In this cohort, hepatic abnormalities were observed in some patients before the Fontan operation and new abnormalities developed soon afterward. These findings suggest that liver insult may occur before or soon after the Fontan operation.
Authors: William N Evans; Ruben J Acherman; Leigh C Reardon; Alvaro Galindo; Abraham Rothman; Michael L Ciccolo; Sergio A Carrillo; Brody J Winn; Noel S Yumiaco; Humberto Restrepo Journal: Pediatr Cardiol Date: 2016-05-09 Impact factor: 1.655
Authors: David J Goldberg; Lea F Surrey; Andrew C Glatz; Kathryn Dodds; Michael L O'Byrne; Henry C Lin; Mark Fogel; Jonathan J Rome; Elizabeth B Rand; Pierre Russo; Jack Rychik Journal: J Am Heart Assoc Date: 2017-04-26 Impact factor: 5.501
Authors: Giulia Perucca; Charlotte de Lange; Stéphanie Franchi-Abella; Marcello Napolitano; Michael Riccabona; Damjana Ključevšek; Seema Toso; Jochen Herrmann; Samuel Stafrace; Kassa Darge; Maria Beatrice Damasio; Costanza Bruno; Magdalena Maria Woźniak; Luisa Lobo; Donald Ibe; Anne M Smets; Philippe Petit; Lil-Sofie Ording Müller Journal: Pediatr Radiol Date: 2021-10-15